ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 182 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,035,728 | +61.3% | 221,257 | +82.9% | 0.01% | +50.0% |
| Q4 2022 | $2,501,536 | -20.4% | 120,964 | +0.7% | 0.01% | -25.0% |
| Q3 2022 | $3,142,000 | +76.3% | 120,108 | +70.8% | 0.01% | +100.0% |
| Q2 2022 | $1,782,000 | +769.3% | 70,333 | +1098.4% | 0.00% | – |
| Q3 2021 | $205,000 | -80.2% | 5,869 | -84.4% | 0.00% | -100.0% |
| Q2 2021 | $1,034,000 | -22.0% | 37,639 | -20.3% | 0.00% | 0.0% |
| Q1 2021 | $1,326,000 | -22.5% | 47,226 | -28.4% | 0.00% | -33.3% |
| Q4 2020 | $1,712,000 | +52.6% | 65,966 | +0.8% | 0.00% | +50.0% |
| Q3 2020 | $1,122,000 | -22.0% | 65,440 | +12.5% | 0.00% | 0.0% |
| Q2 2020 | $1,439,000 | +298.6% | 58,162 | +123.9% | 0.00% | +100.0% |
| Q1 2020 | $361,000 | +32.7% | 25,976 | -3.6% | 0.00% | – |
| Q4 2019 | $272,000 | – | 26,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $42,172,000 | 23.15% |
| Octagon Capital Advisors LP | 2,668,316 | $69,803,000 | 12.05% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $22,754,000 | 8.25% |
| Finepoint Capital LP | 646,586 | $16,915,000 | 5.56% |
| PFM Health Sciences, LP | 3,383,233 | $88,505,000 | 3.20% |
| BVF INC/IL | 2,717,020 | $71,077,000 | 2.94% |
| Boxer Capital, LLC | 1,432,200 | $37,466,000 | 2.11% |
| DAFNA Capital Management LLC | 178,717 | $4,675,000 | 1.26% |
| SECTORAL ASSET MANAGEMENT INC | 227,032 | $5,939,000 | 1.17% |
| HighVista Strategies LLC | 71,650 | $1,874,000 | 1.07% |